Please note that compounded medications offered through our services are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality
For example, if a new GLP-1 were an infusion drug, the patient might pay the full coinsurance on thousands of dollars of service
Setting realistic expectations is crucial, as weight loss is a gradual journey

Adverse Reactions/Side Effects The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Acute Gallbladder Disease [see Warnings and Precautions (5.3)] Hypoglycemia [see Warnings and Precautions (5.4)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.5)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.6)] Hypersensitivity Reactions [see Warnings and Precautions (5.7)] Diabetic Retinopathy Complications in Patients with Type 2 Diabetes [see Warnings and Precautions (5.8)] Heart Rate Increase [see Warnings and Precautions (5.9)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.10)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice

We discuss growing concerns about AIs return on investment, why Netflix co-CEO Ted Sarandos believes Hollywoods fears may be overblown, and why Eli Lilly CEO David Ricks thinks GLP-1 drugs could prove even more transformative than artificial intelligence